Quantitative multivoxel proton MR spectroscopy study of brain metabolites in patients with amnestic mild cognitive impairment: A pilot study

Neuroradiology

Volumn 54, Issue 5, 2012, Pages 451-458

  Yang, Zhong Xian ^a   Huo, Shan Shan ^b   Cheng, Xiao Fang ^a   Xu, Zhi Feng ^a   Cao, Zhen ^a   Zeng, Jie Xia ^a   Xiao, Ye Yu ^a   You, Ke Zeng ^a   Chen, Wei ^a   Liu, Yan Yan ^a   Wu, Ren Hua ^a  

^a SHANTOU UNIVERSITY MEDICAL COLLEGE   (China)

^b SHANTOU UNIVERSITY   (China)

Author keywords

Amnesic mild cognitive impairment; Multivoxel; Proton magnetic resonance spectroscopy

Indexed keywords

CHOLINE; CREATINE; INOSITOL; N ACETYLASPARTIC ACID;

ADULT; ARTICLE; BRAIN METABOLISM; CLINICAL ARTICLE; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; DATA PROCESSING; DIAGNOSTIC IMAGING; FEMALE; GRAY MATTER; HUMAN; INFERIOR PRECUNEUS; LENTIFORM NUCLEUS; MALE; METABOLIC PARAMETERS; METABOLITE; METABOLITE RATIO; MILD COGNITIVE IMPAIRMENT; MULTIVOXEL PROTON NUCLEAR MAGNETIC RESONANCE POINT RESOLVED SPECTROSCOPY; NEUROIMAGING; NUCLEAR MAGNETIC RESONANCE SCANNER; PARATRIGONAL WHITE MATTER; PILOT STUDY; POSTERIOR CINGULATE; PRECUNEUS; PRIORITY JOURNAL; PROTON NUCLEAR MAGNETIC RESONANCE; QUANTITATIVE ANALYSIS; QUANTITATIVE STUDY; THALAMUS; WHITE MATTER;

AMNESIA; ASPARTIC ACID; BRAIN CHEMISTRY; CASE-CONTROL STUDIES; CHOLINE; CREATINE; FEMALE; HUMANS; IMAGE INTERPRETATION, COMPUTER-ASSISTED; INOSITOL; MAGNETIC RESONANCE IMAGING; MAGNETIC RESONANCE SPECTROSCOPY; MALE; MIDDLE AGED; NEUROPSYCHOLOGICAL TESTS; PILOT PROJECTS; PROTONS;

EID: 84863010434     PISSN: 00283940     EISSN: 14321920     Source Type: Journal    
DOI: 10.1007/s00234-011-0900-0     Document Type: Article

References (53)

1. Gauthier S, Reisberg B, Zaudig M et al (2006) Mild cognitive impairment. Lancet 367:1262-1270
2. Mucke L (2009) Neuroscience: Alzheimer's disease. Nature 461:895-897
3. Petersen RC (2007) Mild cognitive impairment: current research and clinical implications. Semin Neurol 27:22-31 (Pubitemid 46239036)
4. Johnson KA, Jones K, Holman BL et al (1998) Preclinical prediction of Alzheimer's disease using SPECT. Neurology 50:1563-1571 (Pubitemid 28283219)
5. McKelvey R, Bergman H, Stern J et al (1999) Lack of prognostic significance of SPECT abnormalities in non-demented elderly subjects with memory loss. Can J Neurol Sci 26:23-28 (Pubitemid 29088320)
6. Petersen RC, Doody R, Kurz A et al (2001) Current concepts in mild cognitive impairment. Arch Neurol 58:1985-1992 (Pubitemid 33143977)
7. Morris JC, Storandt M, Miller JP et al (2001) Mild cognitive impairment represents early-stage Alzheimer disease. Arch Neurol 58:397-405 (Pubitemid 32217456)
8. Grundman M, Petersen RC, Ferris SH et al (2004) Mild cognitive impairment can be distinguished from Alzheimer disease and normal aging for clinical trials. Arch Neurol 61:59-66 (Pubitemid 38067415)
9. 1H MRS changes in mild cognitive impairment and Alzheimer's disease. Neurobiol Aging 28:1330-1339 (Pubitemid 47081237)
10. Chao LL (2010) Evidence of neurodegeneration in brains of older adults who do not yet fulfill MCI criteria. Neurobiol Aging 31:368-377
11. Rosen Y, Lenki RE (2007) Recent advances in magnetic resonance neurospectroscopy. Neurotherapeutics 4:330-345 (Pubitemid 46962408)
12. Kizu O, Yamada K, Ito H et al (2004) Posterior cingulate metabolic changes in frontotemporal lobar degeneration detected by magnetic resonance spectroscopy. Neuroradiology 46:277-281 (Pubitemid 38594249)
13. 1H MR spectroscopy of the brain: absolute quantification of metabolites. Radiology 240:318-332 (Pubitemid 44098628)
14. 1H MRS brain metabolite concentrations in vivo. Magn Reson Imaging 21:787-797 (Pubitemid 37259906)
15. Doelken MT, Mennecke A, Stadlbauer A et al (2009) Multi-voxel magnetic resonance spectroscopy of cerebral metabolites in healthy adults at 3 Tesla. Acad Radiol 16:1493-1501
16. 1H-spectra with LCModel. NMR Biomed 14:260-264 (Pubitemid 32611437)
17. Waldman AD, Rai GS (2003) The relationship between cognitive impairment and in vivo metabolite ratios in patients with clinical Alzheimer's disease and vascular dementia: a proton magnetic resonance spectroscopy study. Neuroradiology 45:507-512 (Pubitemid 37080861)
18. Ackl N, Ising M, Schreiber YA et al (2005) Hippocampal metabolic abnormalities in mild cognitive impairment and Alzheimer's disease. Neurosci Lett 384:23-28
19. 1H-MR spectroscopy differentiates mild cognitive impairment from normal brain aging. Neuroreport 12:2315-2317 (Pubitemid 32682179)
20. Schuff N, Meyerhoff DJ, Mueller S et al (2006) N-Acetylaspartate as a marker of neuronal injury in neurodegenerative disease. Adv Exp Med Biol 576:241-262
21. 1H magnetic resonance spectroscopic imaging. Alzheimer Dis Assoc Disord 231:57-62
22. Dixon RM, Bradley KM, Budge MM et al (2002) Longitudinal quantitative proton magnetic resonance spectroscopy of the hippocampus in Alzheimer's disease. Brain 125:2332-2341
23. Jessen F, Block W, Traber F et al (2000) Proton MR spectroscopy detects a relative decrease of N-acetylaspartate in the medial temporal lobe of patients with AD. Neurology 55:684-688
24. Petersen RC, Smith GE, Waring SC et al (1999) Mild cognitive impairment clinical characterization and outcome. Arch Neurol 56:303-308 (Pubitemid 29120227)
25. Morris JC (1993) The clinical dementia rating (CDR): current version and scoring rules. Neurology 43:2412-2414 (Pubitemid 23346995)
26. Folstein MF, Folstein SE, McHugh PR (1975) Mini mental state: a practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 12:189-198
27. Barberger-Gateau P, Commenges D, Gagnon M et al (1992) Instrumental activities of daily living as a screening tool for cognitive impairment and dementia in elderly community dwellers. J Am Geriatr Soc 40:1129-1134
28. Chang CC, Kramer JH, Lin KN et al (2010) Validating the Chinese version of the verbal learning test for screening Alzheimer's disease. J Int Neuropsychol Soc 16:244-251
29. Reisberg B, Ferris SH, de Leon MJ et al (1982) The global deterioration scale for assessment of primary degenerative dementia. Am J Psychiatry 139:1136-1139 (Pubitemid 12051593)
30. Larson DB, Lyons JS, Bareta JC et al (1989) The construct validity of the ischemic score of Hachinski for the detection of dementias. J Neuropsychiatry Clin Neurosci 1:181-187 (Pubitemid 19247963)
31. Nasreddine ZS, Phillips NA, Bedirian V et al (2005) The Montreal Cognitive Assessment, MoCA: a brief screening tool for mild cognitive impairment. J Am Geriatr Soc 4:695-699 (Pubitemid 41623495)
32. 1H echo-planar spectroscopic imaging. Magn Reson Med 53:465-469 (Pubitemid 40171061)
33. Minoshima S, Giordani B, Berent S et al (1997) Metabolic reduction in the posterior cingulate cortex in very early Alzheimer's disease. Ann Neurol 42:85-94 (Pubitemid 27304784)
34. Huang CR, Wahlund LO, Svensson L et al (2002) Cingulate cortex hypoperfusion predicts Alzheimer's disease in mild cognitive impairment. BMC Neurol 2:9. doi:10.1186/1471-2377-2-9 (Pubitemid 38729081)
35. Chételat G, Desgranges B, de la Sayette V et al (2003) Mild cognitive impairment: can FDG-PET predicts who is to rapidly convert to Alzheimer's disease? Neurology 60:1374-1377 (Pubitemid 36461002)
36. Drzezga A, Lautenschlager N, Siebner H et al (2003) Cerebral metabolic changes accompanying conversion of mild cognitive impairment into Alzheimer's disease: a PET follow-up study. Eur J Nucl Med Mol Imaging 30:1104-1113 (Pubitemid 36988222)
37. Moffett JR, Ross B, Arun P et al (2007) N-Acetylaspartate in the CNS: from neurodiagnostics to neurobiology. Prog Neurobiol 81:89-131 (Pubitemid 46282272)
38. Harada M, Miyoshi H, Otsuka H et al (2001) Multivariate analysis of regional metabolic differences in normal ageing on localised quantitative proton MR spectroscopy. Neuroradiology 43:448-452 (Pubitemid 32591068)
39. Modrego PJ, Fayed N, Pina MA (2005) Conversion from mild cognitive impairment to probable Alzheimer's disease predicted by brain magnetic resonance spectroscopy. J Psychiatry 162:667-675 (Pubitemid 40489127)
40. Rami L, Gómez-Ansón B, Bosch B et al (2007) Cortical brain metabolism as measured by proton spectroscopy is related to memory performance in patients with amnestic mild cognitive impairment and Alzheimer's disease. Dement Geriatr Cogn Disord 24:274-279 (Pubitemid 47482074)
41. Scahill RI, Schott JM, Stevens JM et al (2002) Mapping the evolution of regional atrophyin Alzheimer's disease: unbiased analysis of fluid-registered serial MRI. Proc Natl Acad Sci USA 99:4703-4707 (Pubitemid 34286048)
42. Fayed N, Dávila J, Oliveros A et al (2008) Utility of different MR modalities in mild cognitive impairment and its use as a predictor of conversion to probable dementia. Acad Radiol 15:1089-1098
43. Olson BL, Holshouser BA, Britt W et al (2008) Longitudinal metabolic and cognitive changes in mild cognitive impairment patients. Alzheimer Dis Assoc Disord 22:269-277
44. Metastasio A, Rinaldi P, Tarducci R et al (2006) Conversion of MCI to dementia: role of proton magnetic resonance spectroscopy. Neurobiol Aging 27:926-932
45. 1H MR spectroscopy in common dementias. Neurology 63:1393-1398 (Pubitemid 39426270)
46. Watanabe T, Shiino A, Akiguchi I (2010) Absolute quantification in proton magnetic resonance spectroscopy is useful to differentiate amnesic mild cognitive impairment from Alzheimer's disease and healthy aging. Dement Geriatr Cogn Disord 30:71-77
47. Martínez-Bisbal MC, Arana E, Martí-Bonmatí L et al (2006) Cognitive impairment: classification by proton magnetic resonance spectroscopy and the contributions of conventional magnetic resonance imaging. Radiologia 48:301-307 (Pubitemid 44744477)
48. Selden NR, Gitelman DR, Salamon-Murayama N et al (1998) Trajectories of cholinergic pathways within the cerebral hemispheres of the human brain. Brain 121:2249-2257 (Pubitemid 28552464)
49. 1H magnetic resonance spectroscopic metabolic pattern in the medial temporal lobes of patients with mild cognitive impairment and Alzheimer disease. Brain Res 1003:26-35 (Pubitemid 38317081)
50. 1H MRS changes in mild cognitive impairment and Alzheimer's disease. Neurobiol Aging 28:1330-1339
51. Tiehuis A, van der Meer F, Mali W et al (2010) MR spectroscopy of cerebral white matter in type 2 diabetes; no association with clinical variables and cognitive performance. Neuroradiology 52:155-161
52. Dickerson BC (2010) Advances in quantitative magnetic resonance imaging-based biomarkers for Alzheimer disease. Alzheimers Res Ther 2:21
53. Jahng GH, Xu S, Weiner MW, et al (2011) DTI studies in patients with Alzheimer's disease, mild cognitive impairment, or normal cognition with evaluation of the intrinsic background gradients. Neuroradiology doi:10.1007/s00234-011-0845-3